Holly Vernyi

In this video, Adam Friedman, MD, FAAD, highlighted possible drivers of infection and uncontrolled disease in atopic dermatitis, including immune dysregulation and a lack of microbial dysbiosis.

KIAWAH ISLAND, S.C. — In this video from Kiawah Eye & Retina, Beeran B. Meghpara, MD, highlights the benefits of Epioxa from Glaukos in the treatment of keratoconus.

In this interview Ira Zackon, MD, highlights data on bispecific antibody use in patients with multiple myeloma in the community setting as presented at ASH 2025.

In this video, Mark Sulkowski, MD, discusses data on antisense oligonucleotides or ASO drugs in clinical trials including bepirovirsen and AHB-137.

In this expert perspective from Hawaiian Eye 2025, Roger A. Goldberg, MD, MBA, highlights advancements in the treatment of retinal vein occlusion.

Healio spoke with Ahmad Anouti, MD, a pediatric resident at UT Southwestern Medical Center, about a presentation at The Liver Meeting on how blocking nuclear factor kappa B could correct cellular defects in biliary atresia.Researchers analyzed cholangiocyte organoids from livers of healthy donors and patients with biliary atresia and found that NF-KB activation in biliary atresia promotes

In this video, Elizabeth Lee, MD, of the Dana-Farber Cancer Institute, highlighted promising endometrial cancer presentations from ESMO Congress.

There is a reduction in syringe sharing when methadone providers are spread out near areas with the greatest density of people who inject drugs, according to research presented at The Liver Meeting. Researchers in Chicago established a baseline scenario of spatial access using locations of existing methadone providers in the metropolitan area. The locations of providers were then spatially redistributed based on the densities of the general population and the population of people who inject drug…

The SLEEP annual meeting featured important updates and research in sleep medicine from experts in the field.

New York City-based Eiyan Lens is a new direct-to-consumer contact lens brand created to make quality contact lenses that are affordable and accessible at 58% less than brand-name contact lenses.